Lonza Guangzhou Pharmaceutical Ltd. 68, Huangge Dadaobei
FDA inspection history in Nansha District, China, 2025
- 1
- Form 483
Every document, by year
- Form 483
2025: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2025One Form 483, at Nansha District, China.
Cited most
Across all Lonza Guangzhou Pharmaceutical Ltd. 68, Huangge Dadaobei observations on file
- 21 CFR 211.22Responsibilities of quality control unit2
- 21 CFR 211.192Production record review1
- 21 CFR 211.198Complaint files1
The complete Lonza Guangzhou Pharmaceutical Ltd. 68, Huangge Dadaobei file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Nansha District, China
One Form 483 · 2025 · 3 observations
Latest: Form 483, Oct 31, 2025 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2025-10-31 | 483 Form 483 | Nansha District, China | 3 | $99 |
Investigators on these documents
FEI number 3006532186 · most recent document Oct 31, 2025
About Lonza Guangzhou Pharmaceutical Ltd. 68, Huangge Dadaobei
How many FDA Form 483s has Lonza Guangzhou Pharmaceutical Ltd. 68, Huangge Dadaobei received?
FDA Intel has 1 Form 483 on file for Lonza Guangzhou Pharmaceutical Ltd. 68, Huangge Dadaobei; the most recent is dated Oct 31, 2025.
When was Lonza Guangzhou Pharmaceutical Ltd. 68, Huangge Dadaobei last inspected by FDA?
The most recent FDA inspection document on file for Lonza Guangzhou Pharmaceutical Ltd. 68, Huangge Dadaobei is a Form 483 dated Oct 31, 2025, for the site in Nansha District, China.
What did FDA cite at Lonza Guangzhou Pharmaceutical Ltd. 68, Huangge Dadaobei?
The regulations cited most in the observations on file for Lonza Guangzhou Pharmaceutical Ltd. 68, Huangge Dadaobei are 21 CFR 211.22 (Responsibilities of quality control unit), 2 times; 21 CFR 211.192 (Production record review), 1 time; 21 CFR 211.198 (Complaint files), 1 time.